Iberogast (Milk Thistle Fruit Extract, Bitter Candytuft Fresh Plant Extract, Matricaria Liquid Extract, Menthae)

The formulation combines several plant extracts that act on smooth‑muscle tone, gastric motility, and visceral sensitivity. These extracts modulate serotonergic and cholinergic pathways, provide antispasmodic and anti‑inflammatory effects, and help normalize digestive function.

The appropriate dose of Iberogast is determined by the prescribing healthcare professional based on the individual’s condition, age, and response. Patients should follow the prescriber’s instructions and the product label without deviation.

Pregnancy and breastfeeding safety have not been definitively established. Women who are pregnant, planning to become pregnant, or nursing should consult their physician before using Iberogast to weigh potential benefits against any unknown risks.

To place an order, submit an enquiry on the Iberogast product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with single‑ingredient antacids or pro‑kinetic drugs, Iberogast offers a multi‑herbal approach that targets several physiological pathways simultaneously. This broader mechanism may provide symptom relief for a wider range of functional gastrointestinal complaints, though individual response can vary.

Iberogast should be stored at ambient temperature, ideally below 25 °C. Keep the bottle tightly closed in its original packaging, protect it from direct sunlight and moisture, and discard any product that shows discoloration or an off‑odor.

Iberogast is taken orally as a liquid. The recommended method is to measure the prescribed amount using the supplied dosing device and swallow it directly or mix it with a small amount of water, as directed by the healthcare provider.

Serious adverse reactions, although rare, include anaphylaxis, severe skin reactions such as Stevens‑Johnson syndrome, and potential liver injury. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, swelling of the face or throat, rash, or persistent jaundice.

Individuals with known hypersensitivity to any of the herbal components, those with severe liver disease, or patients taking medications that have major interactions (e.g., strong hepatotoxins or anticoagulants) should avoid Iberogast unless advised otherwise by a qualified healthcare professional.